Atezolizumab + intravesical BCG (Bacillus Calmette-Guerin) in high-risk non-muscle invasive bladder cancer (NMIBC) patients: Institutional clinical and translational study (BladderGATE).
作者： Daniel Castellano , Guillermo de Velasco , Maria Cruz Martin Soberón , Alberto Carretero-González , Marta Dueñas
DOI: 10.1200/JCO.2020.38.6_SUPPL.TPS598
关键词: Atezolizumab 、 Standard of care 、 Non muscle invasive 、 Urology 、 Intravesical bcg 、 Resection 、 Bacillus (shape) 、 Medicine 、 Bladder cancer
摘要: TPS598Background: Intravesical Bacillus Calmette-Guerin (BCG) induction + BCG maintenance after transurethral resection (TURBT) is the current standard of care for patients (pt) with high-risk non-...
sci-hub.st 参考文章(0)